Diabetes mellitus, obesity and lipid abnormalities in schizophrenic patients treated with atypical antipsychotics

被引:0
作者
Said, MA [1 ]
Sulaiman, AH [1 ]
Gill, JS [1 ]
机构
[1] Univ Malaya, Kuala Lumpur 59100, Malaysia
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S255 / S255
页数:1
相关论文
共 50 条
[21]   Atypical antipsychotics and cardiovascular risk in schizophrenic patients [J].
Bouchard, RH ;
Demers, MF ;
Simoneau, I ;
Alméras, N ;
Villeneuve, J ;
Mottard, JP ;
Cadrin, C ;
Lemieux, I ;
Després, JP .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (01) :110-111
[22]   Hyperglycaemia and diabetes mellitus associated with atypical antipsychotics [J].
不详 .
SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2005, 95 (04) :230-230
[23]   Relationship of atypical antipsychotics with development of diabetes mellitus [J].
Citrome, LL ;
Jaffe, AB .
ANNALS OF PHARMACOTHERAPY, 2003, 37 (12) :1849-1857
[25]   Risk for diabetes and primary CHD in schizophrenic patients treated with atypical antipsychotics: An analysis of CATIE data using NNH methodology [J].
Cuffel, Brian ;
Nasrallah, Henry ;
Lombardo, Ilise ;
Sorensen, Sonja ;
Revicki, Dennis .
NEUROPSYCHOPHARMACOLOGY, 2006, 31 :S197-S197
[26]   Risk for diabetes and primary CHD in schizophrenic patients treated with atypical antipsychotics: An analysis of catie data using NNH methodology [J].
Cuffel, B. ;
Nasrallah, H. A. ;
Lombardo, I. ;
Sorensen, S. ;
Revicki, D. .
SCHIZOPHRENIA BULLETIN, 2007, 33 (02) :470-471
[27]   Altered face inversion effect in schizophrenic patients treated with typical vs atypical antipsychotics [J].
Tsunoda, T. ;
Uenoyama, M. ;
Nomura, S. ;
Toda, H. ;
Nagamine, M. ;
Shimizu, K. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 :119-119
[28]   Genotype-phenotype Analysis of Paraoxonase 1 in Schizophrenic Patients Treated with Atypical Antipsychotics [J].
Paval, Denis ;
Nemes, Bogdan ;
Rusu, Razvan L. ;
Dronca, Eleonora .
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2018, 16 (01) :32-38
[29]   Urinary incontinence in schizophrenic patients treated with atypical antipsychotics:: urodynamic findings and therapeutic perspectives [J].
La Torre, D ;
Isgrò, S ;
Muscatello, MRA ;
Magno, C ;
Melloni, D ;
Meduri, M .
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2005, 9 (02) :116-119
[30]   Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients [J].
Krakowski, Menahem I. ;
Czobor, Pal ;
Nolan, Karen A. .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (05) :485-493